NQO1 and Platelet storage pool disease: We demonstrated that while fibroblasts from sPD patients had NRF2 and NQO1 mRNA levels decreased, treatment with AntiOxCIN4 increased its NRF2 and NQO1 mRNA levels (Fig. 9A and B, respectively).